Skip to main content

Joseph G. Blute

Member Emeritus

Share:

Joseph Blute retired from Mintz in 2022. He was previously a Member in Mintz’s Litigation Practice.

viewpoints

Over the past several weeks, the Firm has received a number inquiries from clients (on both coasts) who are interested in manufacturing or selling test kits, respirators, masks, and other PPE in response to the COVID-19 pandemic, with respect to potential liability risks associated with such activities.
Read more

Legal Implications of AI

August 27, 2018 | Video

Joe Blute talks about the inevitable legal implications of the transformative artificial intelligence technology and how the legal system will need to continuously evolve to keep up with new developments.
Read more
Today, the Massachusetts Supreme Judicial Court made an important ruling concerning innovator liability with respect to pharmaceuticals. Though precluding negligence and traditional product liability claims against brand-name manufacturers, Chief Justice Gants held that claims alleging intentional, reckless conduct are permitted.
Read more
Read less

News & Press

News Thumbnail
Mintz Member and Co-chair of the firm’s Product Liability Practice Joseph G. Blute was quoted in an article published by Law360 that provided analysis on a recent ruling from the U.S. District Court for the District of Massachusetts granting summary judgment to pharmaceutical company GlaxoSmithKline in a lawsuit alleging that its anti-nausea medication Zofran causes birth defects. Mr. Blute was among legal sources to comment on how the preemption ruling provides a "roadmap" for fending off multidistrict litigation with the help of a landmark U.S. Supreme Court ruling, Merck v. Albrecht.
This article profiles Mintz as one of the 2018 Law360 Massachusetts Powerhouse law firms. Mike Fantozzi, Managing Member of the firm’s Boston office and the Corporate, Tax, Private Client and Immigration Division Head, is quoted providing commentary throughout the piece.
Member Joe Blute provides commentary in this feature article discussing who may be responsible for harm caused to generic drug users in light of state decisions on the matter. Many note, however, that this decision ultimately may rise to the federal level.
Litigation Members Joe Blute, Ralph Campillo and Yalonda Howze are featured in this piece, along with four in-house counsel, discussing the current state of product liability exposures and related litigation. The piece further discusses strategies for manufacturers to minimize product liability exposure, how best to handle discovery, the role testimony from company witnesses plays, among other hot topics.
Press Release Thumbnail
Best Lawyers named 85 Mintz attorneys to its 2018 list of The Best Lawyers in America. In addition, Mintz attorneys Matthew J. Gardella and Samuel M. Tony Starr were named “Lawyer of the Year” in their respective practice areas.
Fifty-three Mintz attorneys have been named Massachusetts Super Lawyers for 2016 and thirty-one have been named Massachusetts Rising Stars. The findings will be published in the November 2016 issue of Boston Magazine and in a stand-alone magazine, New England Super Lawyers. 
Best Lawyers named 73 Mintz attorneys to its 2017 list of The Best Lawyers in America. Mintz attorneys selected for inclusion in this year’s list span 44 practice areas. 
Read less

Events & Speaking

Speaker
Jul
31
2018

ACI's Drug & Medical Device Litigation Boot Camp

American Conference Institute

The Bellevue Hotel Philadelphia, PA

Conference Reference Image
Read less

Joseph G. Blute

Member Emeritus